Literature DB >> 19879297

The use of Bayesian methods for evaluating the performance of a virus-like particles-based ELISA for serology of hepatitis E virus infection in swine.

Nicolas Rose1, Annie Boutrouille, Christelle Fablet, François Madec, Marc Eloit, Nicole Pavio.   

Abstract

In the absence of commercial kits for serological studies specifically for hepatitis E virus (HEV) infection of swine, the capsid protein of a swine genotype 3 HEV was expressed using a recombinant baculovirus. This antigen was used in an enzyme-linked immunosorbent assay (ELISA) for detection of anti-HEV antibodies. Estimation of sensitivity and specificity was carried out in comparison with a commercial serological assay using sera from pigs infected experimentally with HEV genotype 3, negative sera from SPF pigs and swine sera collected at slaughterhouses. Since a "gold standard" is not available, a latent-class Bayesian approach for correlated tests was used to estimate the sensitivity and specificity of both tests. External field and experimental data were used to determine the parameters of Beta prior distributions. The estimated mean sensitivity of the commercial test was 0.47 with a 95% credibility interval of 0.39-0.55, whereas the estimated mean sensitivity of the genotype 3-based assay was 0.92 [0.81-0.99]. The estimated specificities were 0.98 [0.93-0.99] and 0.98 [0.95-0.99] for the genotype 3-based test and commercial test, respectively. In conclusion, genotype 3-antigen derived from swine HEV is a better candidate for assessing hepatitis E serology in swine. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879297     DOI: 10.1016/j.jviromet.2009.10.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States.

Authors:  Chen Dong; Jihong Meng; Xing Dai; Jiu-Hong Liang; Alicia R Feagins; Xiang-Jin Meng; Natalia M Belfiore; Carol Bradford; Joseph L Corn; Carolyn Cray; Gregory E Glass; Melvin L Gordon; Richard A Hesse; Donald L Montgomery; William L Nicholson; Anthony A Pilny; Sheela Ramamoorthy; Douglas D Shaver; Jan Drobeniuc; Michael A Purdy; Howard A Fields; Saleem Kamili; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

Review 2.  Zoonotic hepatitis E: animal reservoirs and emerging risks.

Authors:  Nicole Pavio; Xiang-Jin Meng; Christophe Renou
Journal:  Vet Res       Date:  2010-04-02       Impact factor: 3.683

3.  Serodiagnosis of tuberculosis in Asian elephants (Elephas maximus) in Southern India: a latent class analysis.

Authors:  Shalu Verma-Kumar; David Abraham; Nandini Dendukuri; Jacob Varghese Cheeran; Raman Sukumar; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

4.  Development and validation of a genotype 3 recombinant protein-based immunoassay for hepatitis E virus serology in swine.

Authors:  W H M van der Poel; N Pavio; J van der Goot; M van Es; M Martin; B Engel
Journal:  Braz J Med Biol Res       Date:  2014-03-21       Impact factor: 2.590

Review 5.  From the epidemiology of hepatitis E virus (HEV) within the swine reservoir to public health risk mitigation strategies: a comprehensive review.

Authors:  Morgane Salines; Mathieu Andraud; Nicolas Rose
Journal:  Vet Res       Date:  2017-05-25       Impact factor: 3.683

6.  Combining network analysis with epidemiological data to inform risk-based surveillance: Application to hepatitis E virus (HEV) in pigs.

Authors:  Morgane Salines; Mathieu Andraud; Nicolas Rose
Journal:  Prev Vet Med       Date:  2017-11-20       Impact factor: 2.670

7.  Detection of serum antibodies to hepatitis E virus in domestic pigs in Italy using a recombinant swine HEV capsid protein.

Authors:  Eleonora Ponterio; Ilaria Di Bartolo; Ginevra Orrù; Manuel Liciardi; Fabio Ostanello; Franco Maria Ruggeri
Journal:  BMC Vet Res       Date:  2014-06-16       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.